Massive Bio works with a number of key partners around the world to deliver the best treatment options for people diagnosed with cancer. Through these collaborative relationships, patients, family members, and physicians worldwide have easy access to Massive Bio’s proprietary SYNERGY AI® clinical trial matching system and Virtual Tumor Board services. This provides assurance that no matter where patients live, they receive the latest available and most effective therapies for their unique situations.

Philips Healthworks

Philips Healthworks is an accelerator program from Philips which aims to tackle some of the biggest and most complex challenges in healthcare. It offers aspiring entrepreneurs access to healthcare partners, global innovation hubs and technology platforms that, in turn, help startups, de-risk and accelerate time-to-revenue.

Optimal Research

Optimal Research provides Just-in-Time clinical trial access solutions to sponsors, sites and patients involved in cancer research or looking for options. Its global site community can activate a clinical trial in 2-weeks from patient pre-qualification assuring every cancer patient can access any trial made available Just-in-Time by sponsors. Optimal Research helps providers and patients make local access to cutting edge therapies possible in real time.

War Memorial Hospital

War Memorial Hospital has served communities for more than 100 years and employs more than 880 individuals who are deeply committed to delivering patient-focused care.

Cancer Patient Data Solutions and Clinical Trial Improvement

Patient Data Solutions

Clinerion is the worldwide leader in medical data informatics, radically improving efficiency in patient search and identification, increasing effectiveness in clinical research and accelerating the process of drug development to ensure an earlier availability of medicines.

Massive Bio's partnership with Clinerion offers access to oncology patient insights for site outreach and identification of cohorts for trial site selection and patient recruitment. Clinerion’s Patient Network Explorer renders hospital information systems with different data models, terminologies and ontologies mutually intelligible, allowing users to send a single query to the entire network and receive meaningful, actionable patient data insights. Clinerion’s network today covers 74M patients in 19 countries around the world.


Mount Sinai Icahn School of Medicine

Vendor neutral evaluation of molecular profiling reports

In collaboration with Dr. Zeynep Gumus and her lab at the Icahn Institute of Genetics and Genomic Sciences, Massive Bio performs vendor-neutral evaluations of molecular profiling technologies. The goal is to make the reports easier to understand for both the local oncologist and patient, which leads to increased adoption of targeted treatments for the patient’s specific tumor. We achieve this by conducting ongoing surveys with oncologists and patients so we can continue to make, on molecular profile reports even more intuitive and insightful to treatment strategies.

Critical Outcome Technologies

Advanced Molecular Diagnostics

Admera Health is an advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing and digital health.

Dedicated to developing cutting-edge diagnostics that span the continuum of care, Admera Health fulfills unmet medical needs with cost-effective tests and accurate analysis to guide patient care. Utilizing next generation technology platforms and advanced bioinformatics, Admera Health seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions.

Hematology Oncology Associates of Palm Beach

Hematology Oncology Associates was established in Palm Beach County over 35 years ago, and has grown to include 7 Board Certified Hematologist and Oncologists in 3 convenient locations.

Intergen Genetic Diagnosis Center

Intergen conducts more than 1,500 varieties of genetic testing; Massive Bio is a channel partner of Intergen to provide tumor board services for already profiled patients.

Second Opinion Expert

State-of-the-art technology platform

We l leverage SecondOpinionExpert’s cutting edge information technology and network of top medical experts with Massive Bio’s world-class multidisciplinary cancer team of medical oncologists, molecular diagnostic scientists, reimbursement experts, and data scientists. Our, partnership will make precision oncology accessible, affordable, and personalized for patients around the globe.

Beat 19

Beat19 is an IRB approved research study centered around learning and understanding the effects of coronavirus (Covid-19) on cancer patients. Surveys are administered daily asking patients about their symptoms and medications related to COVID-19. All Findings will be shared by the Beat19 team in a comprehensive report at the conclusion of the study.

Remed Assistance

Remed Assistance operates in Europe, Middle East, and elsewhere worldwide to provide value-added medical tourism, health, and insurance services. Massive Bio expands its outreach by leveraging Remed Assistance’s vast international insurer network, granting their clients easy access to Massive Bio and our array of services.

Anadolu Medical Center

Anadolu Medical Center provides healthcare services to patients from 30 countries in a most comprehensive and modern way. Massive Bio reviews complex cases for patients in Anadolu Center’s network who do not have the ability to come to the United States for care, but still want access to leading therapies they can receive at home.

Neolife Medical Center

Neolife is a leader in the oncology medical services market in Romania and one of the reference clinics for healthcare services in Central and Eastern Europe. Neolife and Massive Bio joined forces to support advanced staged cancer patients who require extensive treatment analysis US-based experts.


Genomize is a young, dynamic, and fast-growing biotech-startup specializing in genome-level data production and analysis. The company delivers years of bioinformatics know-how for project-specific needs in the pharmaceutical industry and multiple academic settings.

Onko Koçsel

Onko Koçsel Pharmaceuticals has first taken its place in the pharmaceutical sector in 1987 by introducing blood derivative products in Turkey and becoming an exclusive distributor for the reputable European companies such as Caris Life Sciences Europe. Onto Koçsel is a channel partner of Massive Bio; uses its local sales force to train local oncologists in Massive Bio products and benefits of precision oncology.

Redox Engine

Interoperate with multiple health IT systems

Health IT systems traditionally have differences that make connecting with outside systems difficult. Our relationship with Redbox Engine allows us to easily exchange information between multiple systems, breaking down barriers that would otherwise cause delays in treatment planning. By linking to each hospital's raw HL7 formatted data, and translating it into a standardized nomenclature, Redox enables Massive Bio to create a platform that works with many different electronic medical record systems.

Egypt Assistance

Egypt Assistance was established in 2003 as a subsidiary of Remed Assistance. Egypt Assistance provides a wide range of services to its clients from various sectors, not only in Egypt but also in neighboring countries, especially UAE, Tunisia, and Morocco. They specialize in coordinating local and international travel, medical, legal assistance, and/or cost containment needs for their clients.